Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)Jan Lewis Brandes, David Kudrow, Suzanne Klise et al.|Cephalalgia|2019Cited by 99
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal EpilepsyJacqueline A. French, Mushtaque Chachar, Roger J. Porter et al.|JAMA Neurology|2023Cited by 59
Tramadol/Acetaminophen for the Treatment of Acute Migraine Pain: Findings of a Randomized, Placebo‐Controlled TrialStephen D. Silberstein, Frederick G. Freitag, Todd D. Rozen et al.|Headache The Journal of Head and Face Pain|2005Cited by 49
A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonistDavid Kudrow, Eric Pearlman, Linda Anh B. Nguyen et al.|Headache The Journal of Head and Face Pain|2022Cited by 13
The potential of the Enriched Enrollment Randomized Withdrawal (EERW) paradigm for proof of concept studies of novel agents for the treatment of neuropathic pain (NP)David Hewitt, David Kudrow, Arnold R. Gammaitoni et al.|Journal of Pain|2009Cited by 2